MedPath

Effects of NAVA on diaphragm functio

Not Applicable
Conditions
Health Condition 1: J471- Bronchiectasis with (acute) exacerbationHealth Condition 2: J441- Chronic obstructive pulmonary disease with (acute) exacerbationHealth Condition 3: J439- Emphysema, unspecifiedHealth Condition 4: J459- Other and unspecified asthmaHealth Condition 5: J848- Other specified interstitial pulmonary diseasesHealth Condition 6: J42- Unspecified chronic bronchitis
Registration Number
CTRI/2019/05/019018
Lead Sponsor
Department of Pulmonary Critical Care and Sleep Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. All adult patient (age more than or equal to 18 years) presenting with respiratory failure requiring invasive mechanical ventilation.

2. Patients able to spontaneously trigger the ventilator

Exclusion Criteria

1. Unable to trigger ventilator

2. Moderate or severe acute respiratory distress syndrome (ARDS)

3. Presence of three or more organ system failures

4. Neurological or neuromuscular disease(CVA,GBS,Mysthaeniaetc)

5. Known Phrenic nerve palsy

6. Patient who cannot be ventilated without neuromuscular blockers

7. Patient in shock requiring 2 or more inotropes

8. Any contraindication to the insertion of a nasogastric tube (for example: recent upper gastrointestinal surgery, esophageal varices).

9. Patients on mechanical ventilation for more than 3 days.

10. Patient not willing to participate

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the incidence of diaphragmatic dysfunction (defined as diaphragm thickness fraction less than 20%) in patient ventilated with NAVA as compared to conventional mechanical ventilation.Timepoint: Day 5 or Day of Extubation whichever is earlier
Secondary Outcome Measures
NameTimeMethod
1. Change in thickness of Diaphragm <br/ ><br>2. Diaphragmatic excursion <br/ ><br>3. Diaphragmatic efficiency (NVE and NME) <br/ ><br>Timepoint: Day 5 or Day of Extubation which ever is earlier
© Copyright 2025. All Rights Reserved by MedPath